ABIDJAN, Côte d’Ivoire, 07 August 2024 – Adenia, a leading private equity firm focused on growth opportunities in Africa, has finalized the sale of its 100% equity stake in OMOA Group (“OMOA”) to SPE Capital, a private equity firm focused on the Middle East and Africa.
November 11, 2023 – SPE Capital, an independent private equity firm, announces the sale of Amanys Pharma to Laprophan, a pioneering pharmaceutical company in Morocco, subject to obtaining the required regulatory approvals. This transaction constitutes the second exit for SPE AIF, the USD 260m African-focused fund managed by SPE Capital and which reached final close December 2020.
January 4th, 2023- SPE Capital, an investment firm focused on Africa and the Middle East, announces the acquisition, by its private equity fund SPE AIF I, of a majority stake in Vital, the leading nutritional supplements producer in Tunisia. Vital constitutes the fund’s 9th investment and the 4th in 2022.
SPE Capital is delighted to announce the election to Partner of Tarek Lababidi.
August 5 th , 2022- SPE Capital Partners is pleased to announce the signing of an agreement to sell a controlling stake in Sotipapier, the leading paper packaging manufacturer in Tunisia, to Sango Capital. In addition to acquiring a majority stake in Sotipapier, Sango Capital plans to proceed to a tender offer in accordance with regulations in force. This agreement remains subject to the obtention of the required authorizations from the competent authorities.
SPE Capital announces an agreement for the acquisition of a majority stake in Outsourcia group
SPE Capital acquires GlobalCorp, a leading non-bank financial player in Egypt, alongside Amethis and EBRD
SPE Capital acquires strategic minority stake in Holged from TPG Growth and Satya Capital
SPE Capital announces the promotion of Ahmed El Oraby to Partner
Dislog Group and SPE Capital Partners announce the exit of SPE AIF I from H&S Invest Holding
SPE Capital acquires leading provider of power security solutions in Côte d’Ivoire
SPE Capital Holds Final Close of SPE AIF I
SPE Capital grows leadership team with new Managing Partner
SPE AIF I and Proparco acquire Saham Pharma, a leading antibiotics manufacturer and major hospital provider in Morocco
SPE AIF I invests in H&S Invest Holding Group, the leading fully integrated FMCG distributor in Morocco
SPE AIF I invests in Future Pharmaceutical Industries, a fast-growing Egyptian generic pharmaceuticals manufacturer
SPE Capital successfully completes a dividend recapitalization, partial exit and capital increase in relation to its investment in Sotipapier
SPE Capital successfully exits its investment in orchidia pharmaceutical industries
Meninx Holding and SPE Capital successfully acquired the International School of Carthage (ISC)